Trelegy Ellipta Cost in Ireland
The price of Trelegy Ellipta in Ireland varies depending on the specific strength and the pharmacy. Patients typically purchase Trelegy Ellipta for personal use, and it is not generally available for commercial resale.
How is Trelegy Ellipta Priced for Patients?
The retail price for Trelegy Ellipta can range. For example, Trelegy Ellipta 100mcg/6.7mcg/6.25mcg may be priced around €120-€150. Trelegy Ellipta 200mcg/6.7mcg/6.25mcg could be approximately €140-€170.
What Factors Influence Trelegy Ellipta's Price?
The cost of Trelegy Ellipta is influenced by several factors:
* Strength: Different strengths of the medication will have different price points [1].
* Pharmacy: Prices can differ between pharmacies due to their pricing strategies and overhead costs [1].
* Prescription Status: Trelegy Ellipta is a prescription-only medication. The price listed is for the medication itself, not including any doctor's consultation fees.
Can I Get Trelegy Ellipta with a Prescription in Ireland?
Yes, Trelegy Ellipta is available in Ireland with a valid prescription from a healthcare professional. Your doctor will determine the most appropriate strength for your condition.
What is Trelegy Ellipta Used For?
Trelegy Ellipta is a combination inhaler used for the maintenance treatment of asthma in adults. It contains three active ingredients: fluticasone furoate, umeclidinium, and vilanterol [2].
Are There Alternatives to Trelegy Ellipta?
Other inhalers are available for asthma management, which may contain different combinations of medications or single agents. Discussing alternatives with your doctor is important to find the best treatment plan for your individual needs [3].
When Does Trelegy Ellipta's Patent Expire?
Patent expiration dates for medications can be complex and involve multiple patents covering different aspects of the drug and its formulation. Information on patent expiry for specific medications can be found through resources like DrugPatentWatch.com [4].
Sources
1. DrugPatentWatch.com
2. NHS
3. Patient Information Leaflet (PIL) - UK
4. DrugPatentWatch.com